This inventor holds 1 USPTO granted patent. Top assignee: St. Jude Children's Research Hospital. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Marcus Fisher
Introduction
Marcus Fisher is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate protein activity. His work is essential in addressing various clinical conditions, including cancer.
Latest Patents
Marcus Fisher holds a patent for "Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein." This patent describes compounds that are useful as modulators of cereblon (CRBN) activity. The compounds can selectively modulate the degradation of GSPT1 protein, which is crucial in treating disorders associated with uncontrolled cellular proliferation, such as cancer.
Career Highlights
Fisher is currently affiliated with St. Jude Children's Research Hospital, where he continues to advance his research in the pharmaceutical field. His work focuses on developing innovative solutions to combat serious health issues.
Collaborations
He collaborates with talented colleagues, including Fatemeh Keramatnia and Kevin McGowan, to enhance the impact of his research and inventions.
Conclusion
Marcus Fisher's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts are paving the way for new treatments for critical health conditions. His work exemplifies the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile